MyOme at ACMG: Advancing Rare Disease Diagnostics, Room 403A

Join us at MyOme ACMG Corporate Insights Session! Room 403A is where the action is happening. This exclusive event is your chance to gain insights from industry leaders. Don't miss this opportunity to network with professionals in the field. Come and be a part of MyOme ACMG's corporate event - see you there!

Unlocking Genomics: Advancing Rare Disease Diagnostics

This session will provide insights on the potential of whole genome sequencing (WGS) in rare disease diagnostics. It will provide actionable insights into leveraging WGS to uncover elusive diagnoses while highlighting emerging technologies shaping the future of rare disease care. Topic include:

• Move beyond the genome in the Undiagnosed Disease Network with the GREGoR program
• How to use long-read sequencing as an emergent technology in clinical settings including rare disease

Speakers
Akash Kumar, MD, PhD, Chief Medical and Scientific Officer, MyOme
Danny Miller, MD, PhD, FACMG, Assistant Professor, University of Washington
Stephen Montgomery, PhD, Professor, Stanford University

Host or Publisher MyOme